• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名青少年伪装成复杂的原发性EB病毒感染的移植后淋巴细胞增生性疾病。

Post-transplant lymphoproliferative disorder in an adolescent masquerading as a complicated primary EBV infection.

作者信息

Henry Heather L, Fernandez Conrad Vincent, Corsten Gerard

机构信息

Royal College of Surgeons in Ireland, Medicine, 123 St. Stephen's Green, Dublin 2, Ireland.

出版信息

BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.04.2009.1758. Epub 2009 Jun 9.

DOI:10.1136/bcr.04.2009.1758
PMID:21686965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3028415/
Abstract

This report describes an adolescent girl with primary Epstein-Barr virus (EBV) infection in the setting of intensive immunosuppression for a cardiac transplant. She went on to develop progressive pain, weight loss and night sweats with necrosis of the tonsils over 8 weeks. The clinical impression was initially that of a complicated tonsillitis secondary to immune dysfunction. Biopsy 2 months after first presentation demonstrated diffuse B cell lymphoma consistent with post-transplant lymphoproliferative disorder (PTLD). We present this case to highlight the need for a high degree of clinical suspicion for PTLD in a population of patients who commonly experience primary exposure to EBV.

摘要

本报告描述了一名青少年女孩,她在接受心脏移植的强化免疫抑制治疗期间发生了原发性爱泼斯坦-巴尔病毒(EBV)感染。在8周的时间里,她逐渐出现进行性疼痛、体重减轻和盗汗,伴有扁桃体坏死。最初的临床印象是继发于免疫功能障碍的复杂性扁桃体炎。首次出现症状2个月后进行的活检显示为弥漫性B细胞淋巴瘤,符合移植后淋巴细胞增生性疾病(PTLD)。我们报告此病例以强调,对于通常初次接触EBV的患者群体,需要对PTLD保持高度的临床怀疑。

相似文献

1
Post-transplant lymphoproliferative disorder in an adolescent masquerading as a complicated primary EBV infection.一名青少年伪装成复杂的原发性EB病毒感染的移植后淋巴细胞增生性疾病。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.04.2009.1758. Epub 2009 Jun 9.
2
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56NKG2AKIR NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.巨细胞病毒和 Epstein-Barr 病毒合并感染会降低 CD56<sup>NKG2A<sup>KIR<sup>NK 细胞的频率,并导致移植后淋巴组织增生性疾病免疫抑制儿童中 EBV 控制不佳。
Front Immunol. 2020 Jun 17;11:1231. doi: 10.3389/fimmu.2020.01231. eCollection 2020.
3
A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.一项基于人群的实体器官移植后135例淋巴瘤的研究:爱泼斯坦-巴尔病毒、丙型肝炎及弥漫性大B细胞淋巴瘤亚型在临床表现和生存中的作用。
Acta Oncol. 2014 May;53(5):669-79. doi: 10.3109/0284186X.2013.844853. Epub 2013 Oct 28.
4
Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.血清学阴性肾移植受者的原发性爱泼斯坦-巴尔病毒感染、血清转化及移植后淋巴细胞增殖性疾病:一项前瞻性队列研究
Transpl Infect Dis. 2016 Jun;18(3):423-30. doi: 10.1111/tid.12533. Epub 2016 May 23.
5
Epstein-Barr Virus-Negative Diffuse Large B-Cell Post-transplant Lymphoma in an Epstein-Barr Virus-Positive Recipient.爱泼斯坦-巴尔病毒阳性受者中的爱泼斯坦-巴尔病毒阴性弥漫性大B细胞移植后淋巴瘤
Cureus. 2021 Sep 20;13(9):e18134. doi: 10.7759/cureus.18134. eCollection 2021 Sep.
6
Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.初次感染爱泼斯坦-巴尔病毒的肺移植受者的移植后淋巴细胞增生性疾病
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1712-7. doi: 10.1164/ajrccm.154.6.8970360.
7
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.EB 病毒阳性淋巴组织增生性疾病在急性髓系白血病患者中表现为肺部疾病:病例报告。
J Med Case Rep. 2021 Mar 28;15(1):170. doi: 10.1186/s13256-021-02744-2.
8
Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.儿童异基因造血干细胞移植中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病前瞻性预防方案:病毒学监测及一线治疗
Transpl Infect Dis. 2016 Feb;18(1):44-54. doi: 10.1111/tid.12485. Epub 2016 Jan 30.
9
EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.以中枢神经系统原发性弥漫性大B细胞淋巴瘤形式出现的EB病毒阳性移植后淋巴细胞增生性疾病。
Folia Neuropathol. 2017;55(3):221-226. doi: 10.5114/fn.2017.70487.
10
Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact.移植后淋巴增殖性疾病中爱泼斯坦-巴尔病毒阳性与阴性的生物学差异及其临床影响
Front Oncol. 2020 May 8;10:506. doi: 10.3389/fonc.2020.00506. eCollection 2020.

本文引用的文献

1
Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients.小儿肾移植受者中EB病毒载量及杀伤性T细胞的监测
Clin Nephrol. 2008 Nov;70(5):393-403. doi: 10.5414/cnp70393.
2
An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation.心脏移植中一种罕见的移植后淋巴细胞增生性疾病表现,类似血管炎。
J Heart Lung Transplant. 2008 Nov;27(11):1257-61. doi: 10.1016/j.healun.2008.07.029.
3
Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.接受利妥昔单抗治疗的心脏移植患者中,爱泼斯坦-巴尔病毒聚合酶链反应阴性的IV期移植后淋巴增殖性疾病
J Heart Lung Transplant. 2008 Aug;27(8):928-31. doi: 10.1016/j.healun.2008.05.020. Epub 2008 Jul 3.
4
Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.小儿心脏移植患者移植后淋巴细胞增生性疾病的诊断与治疗
Pediatr Transplant. 2009 Feb;13(1):54-62. doi: 10.1111/j.1399-3046.2008.00969.x. Epub 2008 Jun 1.
5
Posttransplant lymphoproliferative disorder.移植后淋巴细胞增生性疾病
Ann Pharmacother. 2007 Nov;41(11):1850-8. doi: 10.1345/aph.1G706. Epub 2007 Oct 16.
6
Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder.头颈部活检在移植后淋巴细胞增生性疾病评估中的作用
Otolaryngol Head Neck Surg. 2007 Aug;137(2):296-300. doi: 10.1016/j.otohns.2007.02.020.
7
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.274例心脏移植受者发生移植后淋巴细胞增生性疾病的经验:来自以色列宾夕法尼亚国际移植肿瘤登记处的报告。
Transplantation. 2004 Dec 15;78(11):1676-82. doi: 10.1097/01.tp.0000144333.19106.58.
8
Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?移植后淋巴细胞增生性疾病(PTLD)是由任何特定的免疫抑制药物引起的,还是由移植本身引起的?
Transplantation. 2003 Sep 27;76(6):984-8. doi: 10.1097/01.TP.0000085602.22498.CF.
9
Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.抗CD20单克隆抗体(利妥昔单抗)治疗小儿肝移植受者中与EB病毒相关的B细胞淋巴增殖性疾病。
J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):389-93. doi: 10.1097/00005176-200204000-00014.
10
Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.移植后淋巴细胞增生性疾病的临床病理特征
Recent Results Cancer Res. 2002;159:9-18. doi: 10.1007/978-3-642-56352-2_2.